Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease: A review article

Gouji Toyokawa, Mitsuhiro Takenoyama, Yukito Ichinose

研究成果: ジャーナルへの寄稿総説査読

15 被引用数 (Scopus)

抄録

Stage III non-small-cell lung cancer (NSCLC) is composed of a heterogeneous population of lesions (ie, T4N0-3, T3N1-3, and T1a-2aN2-3), which makes it difficult to establish a definitive treatment strategy. Although several retrospective and prospective studies have been conducted to investigate the significance of multimodality treatments with surgery for patients with resectable stage III NSCLC, the role of surgery still remains controversial. In this article, we review the results of retrospective and prospective studies that have investigated the significance of multimodality treatment with surgery for patients with stage III NSCLC, particularly those with mediastinal lymph node metastasis, and the implications for the treatment of this controversial subset of patients.

本文言語英語
ページ(範囲)6-14
ページ数9
ジャーナルClinical Lung Cancer
16
1
DOI
出版ステータス出版済み - 1月 1 2015
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 呼吸器内科
  • 癌研究

フィンガープリント

「Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease: A review article」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル